VirnetX Holding Corporation filings document governance, public-company status and material-event disclosures for an internet security software and technology company focused on secure communications and Zero Trust Network Access. Proxy materials cover annual meeting procedures, director and stockholder voting matters and related governance disclosures.
VirnetX's recent Form 8-K filings report Regulation FD announcements, listing-transfer matters and exhibits tied to company press releases. Form 25 records document the voluntary withdrawal of the company's common stock from listing and registration on the New York Stock Exchange, while subsequent filings identify VHC as Nasdaq-listed.
VirnetX Holding Corp (VHC) director Michael F. Angelo sold 1,000 shares of common stock on September 30, 2026, at a weighted average sale price of $10.2550 per share; reported sale prices ranged from $10.00 to $10.56 per share. The sale was made under a Rule 10b5-1 trading plan adopted on May 20, 2026. He directly held 28,209 shares following the sale.
VirnetX Holding Corporation (VHC) entered into an at-the-market sales agreement under which it may sell, from time to time, an aggregate of up to $19,135,717 of common stock under its shelf registration statement. The company is not obligated to sell shares. Titan Partners Securities LLC will act as sales agent and use commercially reasonable efforts to sell shares on the company’s behalf, subject to the agreement.
Sales may be made on The Nasdaq Capital Market or another existing trading market, or to or through a market maker; privately negotiated sales require the company’s prior written consent. VHC agreed to pay the agent a 3.0% commission on the gross sales price of shares sold. The company intends to use net proceeds, if any, for product development, marketing and general corporate purposes, which may include working capital, capital expenditures and other corporate expenses.
VirnetX Holding Corp. (VHC) may offer and sell common stock with an aggregate offering price of up to $19,135,717 through an at-the-market arrangement with Titan Partners Securities LLC as sales agent. VHC receives proceeds from sales and pays the agent a 3% commission on gross sales. If the full amount is sold, VHC estimates net proceeds of approximately $18.2 million after commissions and estimated offering expenses.
VHC expects to use net proceeds for product development and marketing and general corporate purposes, including working capital, capital expenditures and corporate expenses. It may also use some proceeds for acquisitions, licenses or investments in complementary products, technologies or businesses, though it has no agreements or commitments for such transactions. Sales are optional and depend on the number of shares sold and their offering prices. In an illustrative full-sale scenario at $10.32 per share, estimated dilution for new investors is $4.84 per share.
VirnetX Holding Corp. director Michael F. Angelo reported an intended sale of 1,000 common shares, with an aggregate market value of $10,290. The approximate sale date is September 30, 2026, through Apex Clearing on Nasdaq. The shares were acquired from VirnetX Holding Corporation through restricted stock vesting on June 11, 2026; the securities information also lists 4,216,633 shares sold during the past three months.
VirnetX Holding Corp (VHC) reported that President & CEO and ten percent owner Kendall Larsen sold a total of 20,425 shares of common stock in open‑market transactions on September 10, 11, and 14, 2026, under a Rule 10b5-1 trading plan adopted on May 29, 2026. The filing also lists indirect holdings of common stock held by the reporting person’s spouse, a revocable trust, and an investment fund.
VirnetX Holding Corp (VHC) reports that its President & CEO and ten percent owner, Kendall Larsen, sold a total of 14,575 shares of common stock in open-market transactions on August 31, 2026, September 1, 2026, and September 2, 2026, under a Rule 10b5-1 trading plan adopted on May 29, 2026. Indirect holdings reported as of August 31, 2026, include 74,649 shares held by a spouse, 30,676 shares held by the Kathleen Sheehan Revocable Trust, and 15,000 shares held by The K2 Investment Fund LLC.
VirnetX Holding Corp (VHC) director Gary Feiner reported open-market sales of an aggregate 7,500 shares of common stock in late August and early September 2026. The trades were effected under a Rule 10b5-1 trading plan adopted on May 29, 2026, with prices reported on a weighted-average basis within disclosed ranges.
VirnetX Holding Corp (VHC) received a Rule 144 notice from officer Kendall Larsen covering a proposed sale of 35,000 shares of common stock through Apex Clearing. The shares, acquired on 04/01/2009 via restricted stock vesting and stock option exercise, have an aggregate market value of $477,050, with 4,216,633 shares of common stock outstanding and an intended sale no later than 08/31/2026.
VirnetX Holding Corp (VHC) received a Rule 144 notice from director Gary Feiner covering a potential future sale of company stock. The filing references 7,500 shares of common stock, related to restricted stock vesting, with an approximate sale date of August 31, 2026 through broker Apex Clearing.
VirnetX Holding Corporation reported continued operating losses and liquidity pressure for the quarter ended June 30, 2026. Revenue was $0 for both the three- and six-month periods, compared with $48,000 a year earlier, while operating expenses rose to $4.7 million in the quarter, driven mainly by higher selling, general and administrative costs.
Net loss was $4.5 million for the quarter and $8.9 million for the first half of 2026, increasing from $7.3 million in the prior-year six-month period. Cash and cash equivalents fell to $13.1 million from $15.5 million at year-end, with $7.6 million used in operating activities in the first half.
Total assets were $23.0 million and shareholders’ equity $15.1 million, against total liabilities of $7.9 million. Management concluded that existing liquidity is insufficient to fund operations for 12 months without additional revenue or capital, leading to a going concern warning. The company highlights a $20 million effective shelf registration and continues to focus on commercializing its VirnetX One™, Matrix™, War Room™ and iSCOUT cybersecurity platforms, particularly for U.S. defense, government and critical infrastructure customers.